128 related articles for article (PubMed ID: 9124187)
1. Treatment of fallopian tube carcinoma with cyclophosphamide, adriamycin, and cisplatin.
Cormio G; Maneo A; Gabriele A; Zanetta G; Losa G; Lissoni A
Am J Clin Oncol; 1997 Apr; 20(2):143-5. PubMed ID: 9124187
[TBL] [Abstract][Full Text] [Related]
2. Treatment of primary fallopian tube carcinoma with cisplatin-containing chemotherapy.
Pectasides D; Barbounis V; Sintila A; Varthalitis I; Dimitriadis M; Athanassiou A
Am J Clin Oncol; 1994 Feb; 17(1):68-71. PubMed ID: 8311012
[TBL] [Abstract][Full Text] [Related]
3. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Morris M; Gershenson DM; Burke TW; Kavanagh JJ; Silva EG; Wharton JT
Obstet Gynecol; 1990 Dec; 76(6):1020-4. PubMed ID: 2234710
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Pecorelli S; Vergote I; Curran D; Wagener DJ; Kobierska A; Bolis G; Bokkel-Huinink WT; Lacave AJ; Madronal C; Forn M; de Oliveira CF; Mangioni C; Nooij MA; Goupil A; Kerbrat P; Marth CH; Tumolo S; Herben MG; Zanaboni F; Vermorken JB
Eur J Gynaecol Oncol; 2001; 22(3):187-93. PubMed ID: 11501769
[TBL] [Abstract][Full Text] [Related]
5. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
6. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
7. Treatment of carcinoma of the fallopian tube using cisplatin, doxorubicin, and cyclophosphamide.
Jacobs AJ; McMurray EH; Parham J; Kao MS; Galakatos AE; Perez CA; Camel HM
Am J Clin Oncol; 1986 Oct; 9(5):436-9. PubMed ID: 3776907
[TBL] [Abstract][Full Text] [Related]
8. Results of chemotherapy in advanced carcinoma of the fallopian tube.
Peters WA; Andersen WA; Hopkins MP
Cancer; 1989 Mar; 63(5):836-8. PubMed ID: 2914291
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube.
Gemignani ML; Hensley ML; Cohen R; Venkatraman E; Saigo PE; Barakat RR
Gynecol Oncol; 2001 Jan; 80(1):16-20. PubMed ID: 11136563
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube.
Barakat RR; Rubin SC; Saigo PE; Chapman D; Lewis JL; Jones WB; Hakes TB; Markman M; Reichman B; Hoskins WJ
Gynecol Oncol; 1991 Aug; 42(2):156-60. PubMed ID: 1894176
[TBL] [Abstract][Full Text] [Related]
11. Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer.
Cohen S; Schwartz M; Dottino P; Beddoe AM
J Ovarian Res; 2019 Apr; 12(1):36. PubMed ID: 31027500
[TBL] [Abstract][Full Text] [Related]
12. Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients.
Pectasides D; Pectasides E; Papaxoinis G; Andreadis C; Papatsibas G; Fountzilas G; Pliarchopoulou K; Macheras A; Aravantinos G; Economopoulos T
Gynecol Oncol; 2009 Oct; 115(1):97-101. PubMed ID: 19615725
[TBL] [Abstract][Full Text] [Related]
13. Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.
Colozza M; Mosconi AM; Gori S; Belsanti V; Basurto C; De Angelis V; Giansanti M; Tonato M
Am J Clin Oncol; 1997 Oct; 20(5):522-6. PubMed ID: 9345342
[TBL] [Abstract][Full Text] [Related]
14. Primary carcinoma of the fallopian tube: evidence for activity of cisplatin combination therapy.
Maxson WZ; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE
Gynecol Oncol; 1987 Mar; 26(3):305-13. PubMed ID: 3557196
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.
Conte PF; Bruzzone M; Chiara S; Sertoli MR; Daga MG; Rubagotti A; Conio A; Ruvolo M; Rosso R; Santi L
J Clin Oncol; 1986 Jun; 4(6):965-71. PubMed ID: 3519886
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of primary fallopian tube adenocarcinoma: report of 25 patients.
Wang PH; Yuan CC; Chao HT; Juang CM; Ng HT
Eur J Gynaecol Oncol; 1998; 19(6):571-4. PubMed ID: 10215444
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH
Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355
[TBL] [Abstract][Full Text] [Related]
18. High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma.
Hainsworth JD; Burnett LS; Jones HW; Grosh WW; Johnson DH; Greco FA
J Clin Oncol; 1990 Mar; 8(3):502-8. PubMed ID: 2407811
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: a Danish Ovarian Study Group trial (DACOVA).
Bertelsen K; Jakobsen A; Strøyer J; Nielsen K; Sandberg E; Andersen JE; Ahrons S; Nyland M; Hjortkjaer Pedersen P; Larsen G
Gynecol Oncol; 1993 Apr; 49(1):30-6. PubMed ID: 8482557
[TBL] [Abstract][Full Text] [Related]
20. The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: a comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP).
Hainsworth JD; Jones HW; Burnett LS; Johnson DH; Greco FA
Am J Clin Oncol; 1990 Oct; 13(5):410-5. PubMed ID: 2121019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
